MERS-CoV?Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination

ABSTRACT

We developed an ELISPOT assay for evaluating Middle East respiratory syndrome coronavirus (MERS-CoV)--specific T-cell responses in dromedary camels. After single modified vaccinia virus Ankara-MERS-S vaccination, seropositive camels showed increased levels of MERS-CoV--specific T cells and antibodies, indicating suitability of camel vaccinations in disease-endemic areas as a promising approach to control infection. [ FROM AUTHOR] Copyright of Emerging Infectious Diseases is the property of Centers for Disease Control & Prevention (CDC) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)